{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,3]],"date-time":"2026-08-03T16:58:48Z","timestamp":1785776328435,"version":"3.56.0"},"reference-count":43,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2016,8,1]],"date-time":"2016-08-01T00:00:00Z","timestamp":1470009600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,8,1]],"date-time":"2016-08-01T00:00:00Z","timestamp":1470009600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2016,8,1]],"date-time":"2016-08-01T00:00:00Z","timestamp":1470009600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2016,8,1]],"date-time":"2016-08-01T00:00:00Z","timestamp":1470009600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2016,8,1]],"date-time":"2016-08-01T00:00:00Z","timestamp":1470009600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2016,8,1]],"date-time":"2016-08-01T00:00:00Z","timestamp":1470009600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2016,8,1]],"date-time":"2016-08-01T00:00:00Z","timestamp":1470009600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100002301","name":"Eesti Teadusagentuur","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002301","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003510","name":"Haridus- ja Teadusministeerium","doi-asserted-by":"publisher","award":["10.1-9\/12\/380"],"award-info":[{"award-number":["10.1-9\/12\/380"]}],"id":[{"id":"10.13039\/501100003510","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100008530","name":"European Regional Development Fund","doi-asserted-by":"publisher","award":["0180019s11"],"award-info":[{"award-number":["0180019s11"]}],"id":[{"id":"10.13039\/501100008530","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100008530","name":"European Regional Development Fund","doi-asserted-by":"publisher","award":["2014-2020.4.01.15-0012"],"award-info":[{"award-number":["2014-2020.4.01.15-0012"]}],"id":[{"id":"10.13039\/501100008530","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100008530","name":"European Regional Development Fund","doi-asserted-by":"publisher","award":["ETF8932"],"award-info":[{"award-number":["ETF8932"]}],"id":[{"id":"10.13039\/501100008530","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100008530","name":"European Regional Development Fund","doi-asserted-by":"publisher","award":["PUT177"],"award-info":[{"award-number":["PUT177"]}],"id":[{"id":"10.13039\/501100008530","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100008530","name":"European Regional Development Fund","doi-asserted-by":"publisher","award":["PUT214"],"award-info":[{"award-number":["PUT214"]}],"id":[{"id":"10.13039\/501100008530","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100008530","name":"European Regional Development Fund","doi-asserted-by":"publisher","award":["PUT4"],"award-info":[{"award-number":["PUT4"]}],"id":[{"id":"10.13039\/501100008530","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100008530","name":"European Regional Development Fund","doi-asserted-by":"publisher","award":["SF0180027s08"],"award-info":[{"award-number":["SF0180027s08"]}],"id":[{"id":"10.13039\/501100008530","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004410","name":"European Molecular Biology Organization","doi-asserted-by":"publisher","award":["1819"],"award-info":[{"award-number":["1819"]}],"id":[{"id":"10.13039\/100004410","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100011264","name":"FP7 People: Marie-Curie Actions","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100011264","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000780","name":"European Commission","doi-asserted-by":"publisher","award":["SARMP12219T"],"award-info":[{"award-number":["SARMP12219T"]}],"id":[{"id":"10.13039\/501100000780","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Controlled Release"],"published-print":{"date-parts":[[2016,8]]},"DOI":"10.1016\/j.jconrel.2016.06.006","type":"journal-article","created":{"date-parts":[[2016,6,3]],"date-time":"2016-06-03T16:25:28Z","timestamp":1464971128000},"page":"195-204","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":49,"special_numbering":"C","title":["Pre-administration of PepFect6-microRNA-146a nanocomplexes inhibits inflammatory responses in keratinocytes and in a mouse model of irritant contact dermatitis"],"prefix":"10.1016","volume":"235","author":[{"given":"Egon","family":"Urgard","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annely","family":"Lorents","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mariliis","family":"Klaas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K\u00e4rt","family":"Padari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Janeli","family":"Viil","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toomas","family":"Runnel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kent","family":"Langel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K\u00fclli","family":"Kingo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric","family":"Tkaczyk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"\u00dclo","family":"Langel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toivo","family":"Maimets","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Viljar","family":"Jaks","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Margus","family":"Pooga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6051-1361","authenticated-orcid":false,"given":"Ana","family":"Rebane","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jconrel.2016.06.006_bb0005","doi-asserted-by":"crossref","first-page":"1789","DOI":"10.1126\/science.1152326","article-title":"Multilevel regulation of gene expression by microRNAs","volume":"319","author":"Makeyev","year":"2008","journal-title":"Science (New York, N.Y.)"},{"key":"10.1016\/j.jconrel.2016.06.006_bb0010","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1126\/science.1260969","article-title":"GENE REGULATION. Breakers and blockers-miRNAs at work","volume":"349","author":"Izaurralde","year":"2015","journal-title":"Science (New York, N.Y.)"},{"key":"10.1016\/j.jconrel.2016.06.006_bb0015","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1146\/annurev-immunol-020711-075013","article-title":"MicroRNA regulation of inflammatory responses","volume":"30","author":"O'Connell","year":"2012","journal-title":"Annu. Rev. Immunol."},{"key":"10.1016\/j.jconrel.2016.06.006_bb0020","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1111\/j.1600-065X.2011.01089.x","article-title":"MicroRNAs, new effectors and regulators of NF-kappaB","volume":"246","author":"Boldin","year":"2012","journal-title":"Immunol. Rev."},{"key":"10.1016\/j.jconrel.2016.06.006_bb0025","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1038\/nri2957","article-title":"MicroRNAs: the fine-tuners of Toll-like receptor signalling","volume":"11","author":"O'Neill","year":"2011","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.jconrel.2016.06.006_bb0030","doi-asserted-by":"crossref","first-page":"12481","DOI":"10.1073\/pnas.0605298103","article-title":"NF-kappaB-dependent induction of microRNA miR-146, an inhibitor targeted to signaling proteins of innate immune responses","volume":"103","author":"Taganov","year":"2006","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.jconrel.2016.06.006_bb0035","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1186\/1476-4598-11-71","article-title":"MicroRNA-146a inhibits G protein-coupled receptor-mediated activation of NF-kappaB by targeting CARD10 and COPS8 in gastric cancer","volume":"11","author":"Crone","year":"2012","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.jconrel.2016.06.006_bb0040","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1016\/j.jaci.2014.05.022","article-title":"MicroRNA-146a alleviates chronic skin inflammation in atopic dermatitis through suppression of innate immune responses in keratinocytes","volume":"134","author":"Rebane","year":"2014","journal-title":"J. Allergy Clin. Immunol."},{"key":"10.1016\/j.jconrel.2016.06.006_bb0045","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0000610","article-title":"MicroRNAs: novel regulators involved in the pathogenesis of psoriasis?","volume":"2","author":"Sonkoly","year":"2007","journal-title":"PLoS One"},{"key":"10.1016\/j.jconrel.2016.06.006_bb0050","doi-asserted-by":"crossref","first-page":"1931","DOI":"10.1038\/jid.2014.89","article-title":"MiR-146a negatively regulates TLR2-induced inflammatory responses in keratinocytes","volume":"134","author":"Meisgen","year":"2014","journal-title":"J. Investig. Dermatol."},{"key":"10.1016\/j.jconrel.2016.06.006_bb0055","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1084\/jem.20101823","article-title":"MiR-146a is a significant brake on autoimmunity, myeloproliferation, and cancer in mice","volume":"208","author":"Boldin","year":"2011","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.jconrel.2016.06.006_bb0060","doi-asserted-by":"crossref","first-page":"914","DOI":"10.1016\/j.cell.2010.08.012","article-title":"Function of miR-146a in controlling Treg cell-mediated regulation of Th1 responses","volume":"142","author":"Lu","year":"2010","journal-title":"Cell"},{"key":"10.1016\/j.jconrel.2016.06.006_bb0065","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1038\/nrd4140","article-title":"MicroRNAs and other non-coding RNAs as targets for anticancer drug development","volume":"12","author":"Ling","year":"2013","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.jconrel.2016.06.006_bb0070","doi-asserted-by":"crossref","first-page":"1685","DOI":"10.1056\/NEJMoa1209026","article-title":"Treatment of HCV infection by targeting microRNA","volume":"368","author":"Janssen","year":"2013","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.jconrel.2016.06.006_bb0075","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1038\/nmat3765","article-title":"Delivery materials for siRNA therapeutics","volume":"12","author":"Kanasty","year":"2013","journal-title":"Nat. Mater."},{"key":"10.1016\/j.jconrel.2016.06.006_bb0080","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.pharmthera.2015.07.003","article-title":"Cell-penetrating peptides transport therapeutics into cells","volume":"154","author":"Ramsey","year":"2015","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.jconrel.2016.06.006_bb0085","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.addr.2015.02.008","article-title":"Delivery of therapeutic oligonucleotides with cell penetrating peptides","volume":"87","author":"Boisguerin","year":"2015","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.jconrel.2016.06.006_bb0090","doi-asserted-by":"crossref","first-page":"1627","DOI":"10.1517\/17425247.2015.1046431","article-title":"Cationic PTD\/CPP-mediated macromolecular delivery: charging into the cell","volume":"12","author":"Lonn","year":"2015","journal-title":"Expert Opin. Drug Deliv."},{"key":"10.1016\/j.jconrel.2016.06.006_bb0095","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.4155\/tde.14.72","article-title":"Peptide-mediated delivery: an overview of pathways for efficient internalization","volume":"5","author":"Pae","year":"2014","journal-title":"Ther. Deliv."},{"key":"10.1016\/j.jconrel.2016.06.006_bb0100","doi-asserted-by":"crossref","first-page":"1693","DOI":"10.1016\/j.febslet.2013.04.031","article-title":"Cell-penetrating peptides: 20years later, where do we stand?","volume":"587","author":"Bechara","year":"2013","journal-title":"FEBS Lett."},{"key":"10.1016\/j.jconrel.2016.06.006_bb0105","doi-asserted-by":"crossref","first-page":"1972","DOI":"10.1021\/nn4057269","article-title":"Cell-penetrating peptides: design, synthesis, and applications","volume":"8","author":"Copolovici","year":"2014","journal-title":"ACS Nano"},{"key":"10.1016\/j.jconrel.2016.06.006_bb0110","doi-asserted-by":"crossref","first-page":"3207","DOI":"10.1093\/nar\/gkt1220","article-title":"Cellular trafficking determines the exon skipping activity of Pip6a-PMO in mdx skeletal and cardiac muscle cells","volume":"42","author":"Lehto","year":"2014","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.jconrel.2016.06.006_bb0115","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1021\/mp3003557","article-title":"PepFect14 peptide vector for efficient gene delivery in cell cultures","volume":"10","author":"Veiman","year":"2013","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.jconrel.2016.06.006_bb0120","doi-asserted-by":"crossref","first-page":"3972","DOI":"10.1093\/nar\/gkq1299","article-title":"Design of a peptide-based vector, PepFect6, for efficient delivery of siRNA in cell culture and systemically in vivo","volume":"39","author":"Andaloussi","year":"2011","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.jconrel.2016.06.006_bb0125","doi-asserted-by":"crossref","first-page":"5284","DOI":"10.1093\/nar\/gkr072","article-title":"PepFect 14, a novel cell-penetrating peptide for oligonucleotide delivery in solution and as solid formulation","volume":"39","author":"Ezzat","year":"2011","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.jconrel.2016.06.006_bb0130","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1038\/mt.2008.215","article-title":"A new potent secondary amphipathic cell-penetrating peptide for siRNA delivery into mammalian cells","volume":"17","author":"Crombez","year":"2009","journal-title":"Mol. Ther."},{"key":"10.1016\/j.jconrel.2016.06.006_bb0135","doi-asserted-by":"crossref","first-page":"1961","DOI":"10.1021\/nn304439f","article-title":"Nanoparticle geometry and surface orientation influence mode of cellular uptake","volume":"7","author":"Herd","year":"2013","journal-title":"ACS Nano"},{"key":"10.1016\/j.jconrel.2016.06.006_bb0140","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1038\/nrd4359","article-title":"Therapeutic targeting of microRNAs: current status and future challenges","volume":"13","author":"Li","year":"2014","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.jconrel.2016.06.006_bb0145","doi-asserted-by":"crossref","first-page":"1297","DOI":"10.1016\/j.jaci.2012.02.020","article-title":"Mechanisms of IFN-gamma-induced apoptosis of human skin keratinocytes in patients with atopic dermatitis","volume":"129","author":"Rebane","year":"2012","journal-title":"J. Allergy Clin. Immunol."},{"key":"10.1016\/j.jconrel.2016.06.006_bb0150","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1016\/j.jaci.2012.06.048","article-title":"Atopic dermatitis results in intrinsic barrier and immune abnormalities: implications for contact dermatitis","volume":"131","author":"Gittler","year":"2013","journal-title":"J. Allergy Clin. Immunol."},{"key":"10.1016\/j.jconrel.2016.06.006_bb0155","doi-asserted-by":"crossref","first-page":"2541","DOI":"10.1038\/jid.2014.193","article-title":"Epidermal RelA specifically restricts contact allergen-induced inflammation and apoptosis in skin","volume":"134","author":"Kumari","year":"2014","journal-title":"J. Investig. Dermatol."},{"key":"10.1016\/j.jconrel.2016.06.006_bb0160","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.jaci.2014.02.026","article-title":"Basophils regulate the recruitment of eosinophils in a murine model of irritant contact dermatitis","volume":"134","author":"Nakashima","year":"2014","journal-title":"J. Allergy Clin. Immunol."},{"key":"10.1016\/j.jconrel.2016.06.006_bb0165","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/j.celrep.2012.02.009","article-title":"Regulation of monocyte functional heterogeneity by miR-146a and Relb","volume":"1","author":"Etzrodt","year":"2012","journal-title":"Cell Rep."},{"key":"10.1016\/j.jconrel.2016.06.006_bb0170","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1038\/nrg3978","article-title":"Knocking down disease: a progress report on siRNA therapeutics","volume":"16","author":"Wittrup","year":"2015","journal-title":"Nat. Rev."},{"key":"10.1016\/j.jconrel.2016.06.006_bb0175","doi-asserted-by":"crossref","first-page":"3797","DOI":"10.1021\/nn305754c","article-title":"Molecular parameters of siRNA\u2013cell penetrating peptide nanocomplexes for efficient cellular delivery","volume":"7","author":"van Asbeck","year":"2013","journal-title":"ACS Nano"},{"key":"10.1016\/j.jconrel.2016.06.006_bb0180","article-title":"Characteristics of cell-penetrating peptide\/nucleic acid nanoparticles","author":"Margus","year":"2015","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.jconrel.2016.06.006_bb0185","doi-asserted-by":"crossref","first-page":"1110","DOI":"10.1016\/j.jaci.2011.01.053","article-title":"Contrasting pathogenesis of atopic dermatitis and psoriasis-part I: clinical and pathologic concepts","volume":"127","author":"Guttman-Yassky","year":"2011","journal-title":"J. Allergy Clin. Immunol."},{"key":"10.1016\/j.jconrel.2016.06.006_bb0190","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1111\/j.1749-6632.2012.06554.x","article-title":"Barriers and more: functions of tight junction proteins in the skin","volume":"1257","author":"Kirschner","year":"2012","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.jconrel.2016.06.006_bb0195","doi-asserted-by":"crossref","first-page":"5396","DOI":"10.4049\/jimmunol.175.8.5396","article-title":"Altered CXCR2 signaling in beta-arrestin-2-deficient mouse models","volume":"175","author":"Su","year":"2005","journal-title":"J. Immunol."},{"key":"10.1016\/j.jconrel.2016.06.006_bb0200","doi-asserted-by":"crossref","first-page":"2712","DOI":"10.4049\/jimmunol.169.5.2712","article-title":"Eotaxin (CCL11) and eotaxin-2 (CCL24) induce recruitment of eosinophils, basophils, neutrophils, and macrophages as well as features of early- and late-phase allergic reactions following cutaneous injection in human atopic and nonatopic volunteers","volume":"169","author":"Menzies-Gow","year":"2002","journal-title":"J. Immunol."},{"key":"10.1016\/j.jconrel.2016.06.006_bb0205","doi-asserted-by":"crossref","first-page":"3945","DOI":"10.4049\/jimmunol.0990015","article-title":"The unexpected pleiotropic activities of RANTES","volume":"182","author":"Levy","year":"2009","journal-title":"J. Immunol."},{"key":"10.1016\/j.jconrel.2016.06.006_bb0210","doi-asserted-by":"crossref","first-page":"7652","DOI":"10.1038\/ncomms8652","article-title":"NF-kappaB-induced microRNA-31 promotes epidermal hyperplasia by repressing protein phosphatase 6 in psoriasis","volume":"6","author":"Yan","year":"2015","journal-title":"Nat. Commun."},{"key":"10.1016\/j.jconrel.2016.06.006_bb0215","doi-asserted-by":"crossref","DOI":"10.1038\/oncsis.2012.3","article-title":"MicroRNA-203 functions as a tumor suppressor in basal cell carcinoma","volume":"1","author":"Sonkoly","year":"2012","journal-title":"Oncogenesis"}],"container-title":["Journal of Controlled Release"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168365916303716?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168365916303716?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,3]],"date-time":"2026-08-03T16:34:57Z","timestamp":1785774897000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0168365916303716"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,8]]},"references-count":43,"alternative-id":["S0168365916303716"],"URL":"https:\/\/doi.org\/10.1016\/j.jconrel.2016.06.006","relation":{},"ISSN":["0168-3659"],"issn-type":[{"value":"0168-3659","type":"print"}],"subject":[],"published":{"date-parts":[[2016,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Pre-administration of PepFect6-microRNA-146a nanocomplexes inhibits inflammatory responses in keratinocytes and in a mouse model of irritant contact dermatitis","name":"articletitle","label":"Article Title"},{"value":"Journal of Controlled Release","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jconrel.2016.06.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}